The Diabetes Drug Market is poised for remarkable growth, projected to increase from USD 54.63 billion in 2024 to USD 87.74 billion by 2035, reflecting a compound annual growth rate (CAGR) of 3.80%. This growth trajectory is driven by an increasing global prevalence of diabetes, coupled with advancements in drug development and delivery systems. The rise in awareness about managing diabetes...